CRIS Current Research Information System

SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.093
EU - Europa 16.939
AS - Asia 8.704
AF - Africa 843
OC - Oceania 68
SA - Sud America 66
Continente sconosciuto - Info sul continente non disponibili 17
Totale 54.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.023
GB - Regno Unito 5.358
CN - Cina 3.271
DE - Germania 2.916
SG - Singapore 2.175
IT - Italia 2.094
SE - Svezia 1.907
VN - Vietnam 1.695
UA - Ucraina 1.140
IN - India 1.035
FR - Francia 906
RU - Federazione Russa 821
IE - Irlanda 705
ZA - Sudafrica 449
EE - Estonia 406
JO - Giordania 206
TG - Togo 180
BG - Bulgaria 102
CI - Costa d'Avorio 102
CH - Svizzera 87
SC - Seychelles 84
AT - Austria 82
FI - Finlandia 74
JP - Giappone 67
NL - Olanda 66
BE - Belgio 63
AU - Australia 60
CA - Canada 55
ID - Indonesia 55
HK - Hong Kong 53
GR - Grecia 48
PL - Polonia 41
BR - Brasile 34
ES - Italia 33
LB - Libano 31
RO - Romania 22
CZ - Repubblica Ceca 19
IL - Israele 18
CL - Cile 16
UZ - Uzbekistan 15
EU - Europa 14
IR - Iran 14
MX - Messico 13
TR - Turchia 12
KR - Corea 11
CO - Colombia 8
HU - Ungheria 8
NZ - Nuova Zelanda 8
HR - Croazia 7
NO - Norvegia 7
PK - Pakistan 7
LT - Lituania 6
NG - Nigeria 6
PH - Filippine 6
DZ - Algeria 5
MY - Malesia 5
PT - Portogallo 5
MU - Mauritius 4
PE - Perù 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
DK - Danimarca 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
KE - Kenya 2
MA - Marocco 2
MT - Malta 2
PA - Panama 2
RW - Ruanda 2
SI - Slovenia 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
EC - Ecuador 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
VE - Venezuela 1
Totale 54.730
Salva come PNG Salva come JPEG
Città #
Southend 4.806
Fairfield 4.502
Ashburn 2.463
Woodbridge 2.109
Seattle 1.944
Singapore 1.915
Wilmington 1.867
Houston 1.804
Santa Clara 1.690
Cambridge 1.517
Chandler 1.259
Ann Arbor 1.256
Princeton 1.222
Dong Ket 1.065
Boardman 735
Jacksonville 733
Dublin 700
Westminster 510
Padova 469
Nanjing 457
Berlin 357
Bologna 280
San Diego 274
Saint Petersburg 271
Shenyang 220
Jinan 211
Amman 206
Mülheim 183
Lomé 180
Turin 175
Hebei 166
Nanchang 160
Changsha 143
Beijing 140
Milan 140
Des Moines 124
Guangzhou 108
Tianjin 108
Abidjan 102
Dearborn 100
Jiaxing 99
Sofia 98
Los Angeles 92
Shanghai 92
Mahé 81
Zhengzhou 79
Grafing 78
Hangzhou 69
Falls Church 68
Norwalk 67
Rome 67
Haikou 64
Olalla 64
Vienna 58
Bern 56
Jakarta 55
Ningbo 55
Tokyo 54
London 53
Redwood City 50
Brussels 49
Verona 49
Chicago 46
Bühl 45
Kunming 45
Helsinki 44
Paris 42
Fuzhou 41
Redmond 40
Taizhou 40
San Venanzo 39
Lanzhou 37
Taiyuan 37
Hong Kong 35
Frankfurt am Main 31
Wuhan 31
Medford 30
Sydney 30
Phoenix 29
Lappeenranta 28
Pune 27
Frankfurt Am Main 25
Moscow 25
Warsaw 25
Washington 25
Xi'an 24
New York 23
Toronto 21
Forfar 20
Foshan 20
Hefei 20
São Paulo 20
Catania 18
Chengdu 18
Harbin 18
Plauen 18
Qingdao 18
San Francisco 18
Tappahannock 18
Buffalo 17
Totale 39.256
Salva come PNG Salva come JPEG
Nome #
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone 219
5-HTTLPR and gender differences in affective disorders: A systematic review 188
Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. 185
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes 181
Psychometric characteristic of the Italian version of the Temperament and Character Inventory-Revised (TCI-R). Personality, psychopathology and attachment styles 177
Genetica dei comportamenti impulsivo-aggressivi: possibile applicazione in psichiatria forense? 169
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. 169
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 160
A neural network model for combining clinical predictors of antidepressant response in mood disorders 160
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries 160
Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. 159
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients 158
5-HT(2A) SNPs and the Temperament and Character Inventory 157
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 157
The 5-HT2C receptor as a target for mood disorders. 153
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies 153
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors 153
Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. 152
A systematic review of neurobiological and clinical features of mindfulness meditations 151
Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorder 151
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. 150
A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. 150
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. 150
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients 148
Adenosine Hypothesis of Antipsychotic Drugs Revisited: Pharmacogenomics Variation in Nonacute Schizophrenia 148
Antidepressants and body weight: a comprehensive review and meta-analysis 148
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 147
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 147
Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes 144
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders 143
Correlation of a set of gene variants, life events and personality features on adult ADHD severity 143
A protective genetic variant for adverse environments? The role of childhood traumas and serotonin transporter gene on resilience and depressive severity in a high-risk population 143
5-HT(1A) polymorphism and self-transcendence in mood disorders 142
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 142
Benefit of slow titration of paroxetine to treat depression in the elderly 142
Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) trial 142
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder 141
Association between the estrogen receptor TA polymorphism and Harm avoidance 141
Clinical correlates of augmentation/combination treatment strategies in major depressive disorder 141
Metabolic risk factor profile associated with use of second generation antipsychotics: a cross-sectional study in a community mental health centre 140
Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. 139
Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples 139
The association between electrodermal activity (EDA), depression and suicidal behaviour: A systematic review and narrative synthesis 139
Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders 137
Depressive symptomatology is influenced by chronotypes 137
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 137
COMT and age at onset in mood disorders: a replication and extension study. 137
The role of specific early trauma in adult depression: A meta-analysis of published literature. Childhood trauma and adult depression 136
L'UTILITA' DELLE MEDITAZIONI BASATE SULLA CONSAPEVOLEZZA PER I DISTURBI PSICHIATRICI: UNA REVIEW SISTEMATICA 136
Thyroid hormones affect recovery from depression during antidepressant treatment 133
Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento 133
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial 133
Cariprazine specificity profile in the treatment of acute schizophrenia: A meta-Analysis and meta-regression of randomized-controlled trials 133
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. 132
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls 132
A new prediction model for evaluating treatment-resistant depression 132
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways 131
A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. 131
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial 131
Collaborative meta-Analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression 131
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome 130
Cognitive markers of psychotic unipolar depression: A meta-analytic study 130
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression 129
Association between COMT (Val(158)Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study 128
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines 128
Alcohol Dependence and Genetic Variability in the Serotonin Pathway among Currently and Formerly Alcohol-Dependent Males 128
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades 128
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and schizophrenia in the Korean population. 127
The comparative effects of risperidone long-acting injection and paliperidone palmitate on social functioning in schizophrenia: A 6-month, open-label, randomized controlled pilot trial 127
A genetic dissection of antipsychotic induced movement disorders. 127
Personality and Genetics 126
Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: One-month prospective evaluation. 126
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 126
Genome-wide association study identifies 30 loci associated with bipolar disorder 126
APOE epsilon-4 allele and cytokine production in Alzheimer's disease 125
DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients 125
Antidepressant response in the elderly. 124
A molecular pathway analysis informs the genetic background at risk for schizophrenia 124
Progress and prospects in pharmacogenetics of antidepressant drugs 124
Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study 124
Depression across mood disorders: review and analysis in a clinical sample. 124
Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study. 124
Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia 123
Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients. 122
The pharmacogenomics of selective serotonin reuptake inhibitors. 121
Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls 121
Clinical factors related to schizophrenia relapse 121
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. 120
Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study 120
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment - A European multicentre study 120
Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1 120
Duloxetine plasma level and antidepressant response 120
Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population. 119
Dimensions of major psychoses: a confirmatory factor analysis of six competing models. 119
Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects 119
Temperament and character of suicide attempters 119
TAAR 6 and HSP-70 variations associated with bipolar disorder 119
A targeted use of DNA microarrays in the pharmacogenetics of antidepressants: pros and cons 119
Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis 119
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders 119
Totale 13.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.605 0 0 0 0 0 1.685 2.195 2.302 2.769 990 745 919
2020/20217.549 1.595 631 267 367 137 305 140 582 678 422 348 2.077
2021/20229.193 922 346 678 569 879 569 272 794 311 909 1.658 1.286
2022/20238.083 927 1.151 477 840 509 506 328 456 1.449 242 792 406
2023/20242.420 155 408 196 210 190 373 180 201 106 204 91 106
2024/20257.116 280 1.956 861 827 2.520 672 0 0 0 0 0 0
Totale 55.791